ADC Bio Secures Additional Equity Round Investment
0 Comments
Extra funding for strategic move into downstream formulation and fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm...
Poster dedicated to Lock Release Technology presented at 14th Annual PEGS Boston Conference
Conjugation Process Improvements – Application of Lock Release Technology – Poster presented at the Protein Engineering Summit (Boston)...
ADC Bio secures £1.14m investment from Downing LLP
ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans...
ADC Bio presents Process Technology at Berlin Conference
ADCBIO presented at World ADC Conference on their conjugation process technologies...
Developing A Downstream Bio-Conjugation Process.
ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing....
WHP BUILD CONTRACT AGREED.
ADC BIO has signed a partnership agreement with multi-disciplined engineering specialists, WHP. ...
Poor aggregation will see ADC targets fail or face long delays.
Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs....
ADC BIO Secures $11 Million Facilities Investment.
ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK. ...